When a prescription comes back with a message that prior authorization is required, the natural reaction is to start filling out a PA form. With CVS Caremark, that is not always the best first step. First, find out what is actually preventing the prescription from processing.
This guide walks through that process from prescription verification through authorization, specialty-pharmacy coordination, denial follow-up, renewal tracking, and revenue-cycle considerations.
Essential Insights From This Guide
1. Caremark Is the PBM, but the Member’s Plan Still Matters
2. What Prior Authorization Means in the Caremark Workflow
3. Why Some Caremark Prescriptions Need Additional Review
4. You Begin With a Pharmacy Benefit Check
5. Find the Actual Coverage Restriction
6. Caremark Prescription Review Checklist
7. Prior Authorization, Step Therapy, and Quantity Limits Are Different
8. Check the Current Formulary Before Calling the Prescriber
9. What Information Should Be Ready Before Submission?
10. Make Treatment History Specific
11. The Diagnosis Needs to Match the Clinical Record
12. Caremark Clinical Criteria Should Guide the Documentation
13. Electronic Prior Authorization Is Usually the Most Efficient Starting Point
14. Other Caremark PA Submission Options
15. A Practical Caremark PA Workflow
16. ePA Can Be Fast, but Do Not Promise an Instant Decision
17. What Happens After the Request Is Sent?
18. Suggested Caremark Authorization Tracking Fields
19. Step Therapy Needs a Treatment Timeline
20. Quantity-Limit Requests Need the Math to Work
21. Non-Formulary Drugs May Need an Exception Rather Than a Standard PA
22. Medicare Part D Caremark Requests Need Separate Handling
23. Medicaid Caremark Requests Also Need Plan-Level Verification
24. Specialty Medications Deserve a Separate Work Queue
25. PA Approval Does Not Always Mean the Medication is Ready to Ship
26. Renewals Should Be Tracked Before the Authorization Expires
27. When Caremark Requests More Information
28. Why Caremark PA Requests Get Delayed
29. When Caremark Does Not Approve the Request
30. Appeals Need to Address the Reason for the Decision
31. Caremark Federal Employee Program Requests Can Follow Their Own Rules
32. Pharmacy-Benefit PA and Medical-Benefit PA Are Not Interchangeable
33. Caremark PA and Patient Cost Are Different Questions
34. Prior Authorization Does Not Replace Pharmacy Claim Verification
35. Authorization Errors That Can Disrupt the Prescription
36. Who Handles What in a Caremark PA Workflow?
37. In-House vs. Outsourced Caremark Authorization Support
38. How Caremark PA Connects With the Revenue Cycle
39. How Revenue Cycle Management Can Support Caremark PA Work
40. Final Caremark PA Check Before Closing the Case
41. Frequently Asked Questions About Caremark Prior Authorization
Caremark is the PBM, but the Member’s Plan Still Matters
One of the easiest mistakes to make is thinking that every patient whose pharmacy benefit is administered by CVS Caremark follows the same drug list. Caremark administers pharmacy benefits for different plan sponsors. The member’s specific plan determines the coverage available under that benefit. Caremark’s clinical-criteria resources explicitly state that drug coverage depends on the member’s plan and formulary. That means a medication may:
- Be preferred under one Caremark-administered plan
- Be non-preferred under another
- Require PA under one benefit
- Require step therapy under another
- Carry a quantity limit
- Require a formulary exception
- Be excluded from another plan’s pharmacy benefit
What Prior Authorization Means in the Caremark Workflow
CVS Caremark describes prior authorization as a review process used by the member’s plan to evaluate whether medications, tests, or treatments are clinically appropriate, safe, and affordable. For prescriptions requiring PA, the healthcare provider or an authorized agent provides information so the applicable coverage criteria can be reviewed.
For some plans and medications, the prescriber must supply additional documentation so Caremark or the plan sponsor can determine whether the drug meets applicable criteria. Caremark’s 2026 Provider Manual reinforces that the prescriber may need to supply additional documentation for products subject to PA. From a provider-office perspective, PA therefore means more than obtaining a signature. The request needs to connect:
Patient + Pharmacy Benefit + Medication + Diagnosis + Treatment History + Clinical Criteria + Coverage Rule
Why Some Caremark Prescriptions Need Additional Review
Caremark says medications commonly subject to PA can include drugs that have the potential for overuse, misuse, or off-label use; drugs associated with significant safety concerns; medications used for conditions excluded from the pharmacy benefit; and high-cost drugs. But prior authorization is only one utilization-management tool. CVS Caremark’s utilization-management programs can also include:
- Prior authorization
- Step therapy
- Quantity limits
- Formulary strategies
- Other plan-design controls
You Begin With a Pharmacy Benefit Check
Before anyone starts writing a medical-necessity statement, confirm the pharmacy coverage.
Your staff should identify the member’s current benefit information and determine whether Caremark is actually administering the relevant prescription benefit. Useful information may include:
- Patient name
- Date of birth
- Member ID
- RxBIN
- RxPCN
- RxGroup
- Plan sponsor
- Pharmacy benefit manager
- Effective coverage
- Medication
- Formulary status
Find the Actual Coverage Restriction
Once coverage is verified, determine what the plan is asking the provider to do.
Caremark Prescription Review Checklist
| Item to Verify | Question to Answer |
| Eligibility | Is the pharmacy benefit active? |
| PBM | Is CVS Caremark administering this benefit? |
| Medication | What exact drug was prescribed? |
| Strength | Is the strength correct? |
| Dose | What dose is being prescribed? |
| Frequency | How often will it be taken/administered? |
| Quantity | What amount is requested? |
| Days’ supply | Does it correspond with the quantity? |
| Diagnosis | What condition is being treated? |
| Formulary | Is the medication listed? |
| PA | Does this plan require authorization? |
| Step therapy | Must another drug be tried first? |
| Quantity limit | Does the request exceed the plan limit? |
| Exception | Is non-formulary review required? |
| Specialty | Does specialty pharmacy processing apply? |
Prior Authorization, Step Therapy, and Quantity Limits Are Different in 2027
These terms are often grouped together, but they address different coverage issues.
Prior Authorization
The plan requires clinical review before coverage is provided for the medication.
Step Therapy
Coverage may require the patient to try one or more specified therapies before another medication is covered.
Quantity Limit
The plan may cover the medication only up to a defined quantity or days’ supply unless additional approval is obtained.
Formulary Exception
The prescribed medication may not be on the applicable formulary, requiring an exception request where the plan permits one.
Caremark’s own plan resources show that PA, quantity limits, and step therapy can operate as separate utilization-management requirements.
Your authorization tracker should identify which one is actually being addressed.
Check the Current Formulary Before Calling the Prescriber
A medication’s formulary status can change the entire conversation with the provider in 2027. If the requested medication is preferred and simply needs PA, the clinical team may need to answer medication-specific questions.
If it is non-formulary, the provider may need to decide whether a covered alternative is clinically appropriate or whether an exception should be pursued. If step therapy applies, the office may need to document previous treatment.
If a quantity limit is the problem, the provider may need to justify the prescribed amount. Caremark publishes standard clinical criteria and exception resources by medication or condition, but it warns that actual drug coverage depends on the member’s plan and formulary.
That is why checking the patient’s specific benefit should come before applying a generic Caremark criterion.
What Information Should Be Ready Before Submission?
The exact clinical questions depend on the medication and benefit plan. Still, a well-prepared office should have the core information available before opening the request.
| Information Area | What to Prepare | Why It Helps |
| Patient | Name, DOB, member details | Matches request to coverage |
| Medication | Drug and dosage form | Identifies requested therapy |
| Strength | Exact strength | Prevents prescription mismatch |
| Dose | Amount per administration | Supports regimen |
| Frequency | Dosing schedule | Supports quantity |
| Quantity | Requested amount | Addresses plan limits |
| Days’ supply | Expected coverage period | Helps quantity review |
| Diagnosis | ICD-10-CM/condition | Establishes indication |
| Prescriber | Name, NPI, contact information | Identifies requester |
| Treatment history | Previous medications | Supports clinical criteria |
| Treatment response | Failure/intolerance/etc. | Supports exception/step review |
| Clinical evidence | Notes, labs, tests | Supports medical necessity |
| Rationale | Why medication is needed | Connects evidence to request |
The Diagnosis Needs to Match the Clinical Record
A diagnosis code should not be selected merely because it appears to make the authorization easier. The diagnosis submitted to Caremark should reflect the patient’s actual documented condition. Depending on the medication, clinical review may also look at:
- Disease severity
- Patient age
- Previous treatments
- Treatment duration
- Laboratory results
- Clinical measurements
- Comorbidities
- Contraindications
- Treatment response
- Requested dose
- Prescribing specialty
Caremark Clinical Criteria Should Guide the Documentation
CVS Caremark maintains standard clinical criteria resources covering numerous medications and conditions. Current examples include medication-specific criteria as well as criteria involving quantity limits and post-step-therapy requirements.
Before submitting, compare the available medical record with the questions likely to be asked.
The goal is not to change the clinical record to fit the criteria. The goal is to determine whether the existing, accurate patient record provides the information necessary for a coverage review. If information is missing, coordinate with the prescriber.
Electronic Prior Authorization is Usually the Most Efficient Starting Point
Caremark supports electronic prior authorization, or ePA. Its current provider guidance says ePA can be accessed through a web portal or integrated into an electronic health record. Caremark also identifies integrations with platforms including CoverMyMeds and Surescripts. The ePA process generally works like this:
Prescriber initiates request → Caremark returns clinical question set → Prescriber answers questions → Request is submitted → Clinical information is assessed → Determination is communicated electronically.
Caremark says ePA can reduce unnecessary outreach because required clinical questions are presented electronically. Some automated decisions can be returned in near real time, although Caremark makes clear that this does not occur for every PA type or reason.
Other Caremark PA Submission Options
Electronic submission is not the only pathway. Caremark’s current provider information identifies ePA and telephone submission options and publishes separate contact information for Medicare Part D, Medicaid, and non-Medicare requests. Medicare Part D determination forms and instructions may also depend on the member’s specific plan.
That is another reason not to keep one universal fax number in your office and use it for every Caremark patient. Before submission, determine:
What benefit does the patient have?
What type of request is this?
What submission method applies?
Is a plan-specific form required?
A Practical Caremark PA Workflow
| Stage | Office Action | What to Confirm |
| 1 | Verify pharmacy coverage | Active benefit |
| 2 | Identify PBM | Caremark confirmed |
| 3 | Review prescription | Drug/strength/dose |
| 4 | Check formulary | Current plan coverage |
| 5 | Identify restriction | PA, ST, QL, exception |
| 6 | Review clinical criteria | Medication-specific requirements |
| 7 | Gather treatment history | Previous therapies documented |
| 8 | Collect supporting records | Clinical information complete |
| 9 | Choose submission method | ePA/plan-specific process |
| 10 | Complete clinical questions | Answers match medical record |
| 11 | Submit request | Confirmation retained |
| 12 | Monitor status | Pending requests followed |
| 13 | Answer additional questions | Information sent promptly |
| 14 | Record determination | Approval/denial documented |
| 15 | Coordinate prescription | Pharmacy/specialty pharmacy informed |
| 16 | Track expiration | Renewal planned when needed |
ePA Can Be Fast, but Do Not Promise an Instant Decision
Caremark states that some automated ePA determinations can occur very quickly—even in seconds in certain cases. But it also specifically notes that near-real-time decisions do not apply to all prior authorization types or reasons. Provider offices should therefore avoid telling patients. Caremark will approve this immediately.
Some cases need clinical review.
Some need more information.
Some require an exception.
Others may not meet coverage criteria.
Give patients realistic updates based on the actual request status rather than the speed of another patient’s authorization.
Suggested Caremark Authorization Tracking Fields
| Field | What to Record |
| Patient | Name/MRN |
| Member ID | Pharmacy benefit identifier |
| Plan | Benefit/plan sponsor |
| Medication | Drug name |
| Strength | Prescribed strength |
| Diagnosis | Condition/ICD-10-CM |
| Restriction | PA/ST/QL/exception |
| Date started | PA initiation |
| Date submitted | Final submission |
| Reference | ePA/key/reference number |
| Status | Current status |
| Additional info | Requested/sent |
| Decision | Approved/denied |
| Effective date | Approval begins |
| Expiration | Renewal deadline |
| Pharmacy | Dispensing pharmacy |
| Next action | Follow-up |
Step Therapy Needs a Treatment Timeline
If step therapy applies, your clinical documentation should make previous treatment easy to understand.
| Question | Documentation to Locate |
| What drug was tried? | Medication name |
| What dose? | Prescribed dose |
| For how long? | Treatment period |
| Was it taken appropriately? | Relevant treatment documentation |
| What happened? | Response |
| Why was it stopped? | Failure/intolerance/adverse event |
| Can another preferred drug be used? | Clinical assessment |
| Why is the requested drug appropriate? | Prescriber rationale |
Medicare Part D Caremark Requests Need Separate Handling
Do not automatically apply commercial Caremark rules to Medicare Part D members. Caremark publishes a separate PA contact pathway for Medicare Part D and states that providers seeking a Medicare Part D coverage determination, including PA or exception requests, should follow the member plan’s applicable form and submission instructions. Medicare Part D requests can involve:
- Prior authorization
- Formulary exceptions
- Step-therapy exceptions
- Quantity-limit exceptions
- Tiering exceptions where applicable
Some Caremark-administered Medicare plan resources publish separate forms for each of these request types. Always identify the member’s actual Medicare prescription plan before submitting.
Specialty Medications Deserve a Separate Work Queue
Specialty medications often create more complicated authorization workflows because the drugs may be expensive, clinically complex, and subject to additional dispensing requirements. Depending on the medication and benefit, staff may need to verify:
- Specialty status
- Formulary placement
- PA requirement
- Step therapy
- Diagnosis
- Dose
- Quantity
- Laboratory findings
- Previous therapy
- Prescriber specialty
- Specialty pharmacy requirement
- Approval period
- Renewal criteria
PA Approval Does Not Always Mean the Medication is Ready to Ship
This is particularly important for specialty drugs. After authorization, additional work may remain.
The prescription may still need to reach the correct specialty pharmacy. Patient enrollment may need to be completed. The pharmacy may need to verify benefits. Patient cost-sharing may need to be addressed. Delivery may still need to be scheduled. A good authorization team does not automatically close a specialty medication case and approve. Instead, the workflow continues until the next responsible party has what it needs.
Renewals Should Be Tracked Before the Authorization Expires
Many medication authorizations are approved for a limited period. If the patient is expected to continue therapy, waiting for the pharmacy to receive a rejection at the next refill is inefficient.
Track expiration dates. For renewal cases, the payer may need updated information such as:
- Continued diagnosis
- Treatment response
- Current dose
- Clinical improvement
- Laboratory results
- Adherence
- Adverse effects
- Reason therapy should continue
When Caremark Requests More Information
Additional-information requests should go directly into an active follow-up queue. First determine what is actually missing. It could be:
- Diagnosis clarification
- Treatment dates
- Previous medication history
- Dose
- Quantity
- Laboratory result
- Clinical measurement
- Prescriber specialty
- Contraindication
- Treatment response
- Medical-necessity explanation
Why Caremark PA Requests Get Delayed
Many delays are preventable. Common causes include:
- Incorrect member information
- Wrong pharmacy benefit
- Outdated formulary information
- Incorrect medication or strength
- Missing diagnosis
- Incomplete treatment history
- Step-therapy information missing
- Quantity and days’ supply mismatch
- Missing laboratory values
- Wrong request type
- Non-formulary exception submitted as ordinary PA
- Incomplete clinical questions
- Additional-information request not answered
- Specialty pharmacy coordination not completed
When Caremark Does Not Approve the Request
A denial should trigger review of the determination—not an immediate copy-and-paste resubmission.
| Problem | Possible Reason | Better Next Step |
| Criteria not met | Clinical information does not satisfy plan criteria | Compare decision with record |
| Step therapy | Required treatment history not established | Review prior therapies |
| Quantity limit | Requested amount exceeds coverage | Verify dose and rationale |
| Non-formulary | Drug isn’t covered normally | Review exception options |
| Missing information | Request incomplete | Supply relevant documentation |
| Diagnosis issue | Indication not supported | Verify medical record |
| Benefit exclusion | Medication not covered under benefit | Review plan terms/options |
| Wrong request type | Incorrect workflow used | Identify correct exception/PA route |
Appeals Need to Address the Reason for the Decision
If an appeal or reconsideration is available, the strongest response addresses the actual reason the original request was not approved. Do not simply resend the same packet with “please reconsider” added to the top. Review:
- Decision reason
- Applicable criteria
- Treatment history
- Formulary alternatives
- Clinical findings
- Missing information
- Appeal deadline
- Submission instructions
Caremark Federal Employee Program Requests Can Follow Their Own Rules
Caremark also administers pharmacy prior approval functions for specific benefit arrangements such as the Federal Employee Program. Its FEP prior-approval resources contain drug-specific criteria and forms and note that certain medications can require previous use of other drugs or have quantity thresholds before prior approval is required.
Pharmacy-Benefit PA and Medical-Benefit PA Are Not Interchangeable
Not every medication is necessarily processed through Caremark’s pharmacy benefit. Certain physician-administered medications may be billed through the patient’s medical benefit instead.
Before initiating a Caremark pharmacy PA for an injectable or infused medication, verify:
Where is the drug being obtained?
Where is it administered?
Who bills for it?
Is it covered under the pharmacy or medical benefit?
Which organization manages authorization?
If the medication belongs under the medical benefit, sending a pharmacy PA to Caremark may not resolve the authorization requirement.
Caremark PA and Patient Cost Are Different Questions
Authorization means the plan has reviewed the applicable coverage request.It does not necessarily mean the medication will cost the patient nothing. Patient responsibility can still depend on:
- Deductible
- Copayment
- Coinsurance
- Drug tier
- Specialty tier
- Pharmacy network
- Days’ supply
- Benefit design
- Other plan provisions
Do not quote a patient’s final out-of-pocket cost solely from the PA approval, you must verify the benefits separately.
Prior Authorization Does Not Replace Pharmacy Claim Verification
Even after PA approval, the prescription claim still needs to process correctly. Potential issues can include:
- Coverage termination
- Incorrect pharmacy
- Refill-too-soon edit
- Quantity mismatch
- Wrong days’ supply
- Incorrect NDC
- Authorization expiration
- Network requirements
- Benefit changes
Authorization Errors That Can Disrupt the Prescription
| Error | Possible Result | Prevention |
| Wrong medication | Approval doesn’t match prescription | Verify exact drug |
| Wrong strength | Claim may not align with approval | Reconcile strength |
| Wrong quantity | Pharmacy claim may reject | Check quantity/days’ supply |
| Wrong diagnosis | Clinical criteria may not be met | Use documented diagnosis |
| Wrong plan | Incorrect criteria applied | Verify pharmacy benefit |
| Wrong request | PA used instead of exception | Identify restriction first |
| Expired approval | Refill may reject | Track renewal dates |
| Missing specialty coordination | Drug isn’t dispensed | Follow case through pharmacy |
Who Handles What in a Caremark PA Workflow?
| Activity | Front Desk | Clinical Team | PA Team | Pharmacy/Billing Team |
| Eligibility | ✓ | ✓ | ||
| Pharmacy benefit check | ✓ | ✓ | ||
| Prescription verification | ✓ | ✓ | ||
| Diagnosis | ✓ | ✓ | ||
| Formulary check | ✓ | ✓ | ||
| PA/ST/QL identification | ✓ | |||
| Treatment history | ✓ | ✓ | ||
| Clinical questions | ✓ | ✓ | ||
| Submission | ✓ | |||
| Status follow-up | ✓ | |||
| Additional information | ✓ | ✓ | ||
| Specialty coordination | ✓ | ✓ | ||
| Renewal tracking | ✓ | |||
| Denial feedback | ✓ | ✓ | ✓ |
In-House vs. Outsourced Caremark Authorization Support
| Operational Area | In-House Team | Outsourced Support |
| Benefit checks | Practice staff | Centralized verification |
| Formulary research | Internal workload | Dedicated support |
| PA initiation | Internal team | External PA team |
| Clinical information | Direct provider access | Requires coordination |
| Status tracking | Practice-managed | Central work queue |
| Specialty follow-up | Internal staff | Can be coordinated externally |
| Renewal management | Internal alerts | Dedicated renewal tracking |
| Reporting | Practice-built | Standardized reporting possible |
How Revenue Cycle Management Can Support Caremark PA Work
Revenue Cycle Management can help healthcare organizations organize the administrative side of Caremark and other pharmacy-benefit authorization workflows.
Support can include eligibility and pharmacy-benefit verification, PA requirement checks, formulary and restriction verification, documentation coordination, electronic submission support, status follow-up, specialty-medication coordination, renewal tracking, denial prevention, and medical-versus-pharmacy benefit verification.
The goal is straightforward: identify the correct requirement early and submit the right information the first time.
Final Caremark PA Check Before Closing the Case
Before moving a case out of your authorization queue, confirm:
- Is the patient’s coverage active?
- Is CVS Caremark the correct PBM?
- Did we verify the member’s specific plan?
- Is the exact medication correct?
- Is the strength correct?
- Are dose and frequency documented?
- Does quantity match the days’ supply?
- Is the diagnosis accurate?
- Did we check the current formulary?
- Is this actually prior authorization?
- Does step therapy apply?
- Is there a quantity limit?
- Is a formulary exception needed?
- Did we review current clinical criteria?
- Is previous treatment documented?
- Are failures or intolerances documented accurately?
- Are required labs or clinical findings available?
- Did we use the correct submission pathway?
- Is the request fully submitted?
- Did we save the reference number?
- Have additional-information requests been answered?
- Has a final determination been received?
- Are approval dates recorded?
- Is specialty pharmacy coordination needed?
- Is the renewal date being tracked?
Frequently Asked Questions About Caremark Prior Authorization
What is CVS Caremark prior authorization?
CVS Caremark describes PA as a review process used by a member’s plan to evaluate whether applicable medications meet coverage requirements. The provider or authorized representative may need to answer clinical criteria questions before coverage is determined.
Does every CVS Caremark member follow the same PA list?
No, Caremark specifically states that drug coverage depends on the member’s plan and formulary. Requirements should therefore be verified against the patient’s actual pharmacy benefit.
Which drugs require Caremark prior authorization?
There is no single drug list applicable to every Caremark-administered plan. Caremark notes that medications commonly subject to PA may include high-cost drugs and drugs associated with safety, misuse, off-label-use, or benefit-coverage concerns. The patient’s plan and formulary ultimately determine the applicable requirement.
How can a provider submit a Caremark PA?
Caremark supports electronic PA and telephone submission for applicable requests. ePA can be accessed through supported web-based tools or integrated EHR workflows. Medicare Part D, Medicaid, and non-Medicare requests may have different contact or submission instructions.
Can Caremark prior authorization be completed through CoverMyMeds?
Caremark identifies CoverMyMeds as one of its electronic PA partners. It also supports ePA through other compatible electronic workflows, including Surescripts.
How quickly does Caremark make an ePA decision?
Caremark says some automated ePA decisions can be returned in near real time and that some may be communicated in seconds. However, it explicitly notes that this does not apply to every PA type or reason. Provider offices should not promise a specific turnaround without checking the individual request.
Is step therapy the same as Caremark prior authorization?
Not exactly. Step therapy is a utilization-management requirement that may require previous treatment before another medication is covered. Caremark notes that the term PA may sometimes encompass exception reviews involving step therapy, quantity limits, or non-formulary drugs, but providers should identify the specific restriction involved.
What happens when the requested drug is non-formulary?
Depending on the member’s plan, a formulary exception may be available. The provider may need to document why covered alternatives are clinically inappropriate or why the requested medication is necessary. Check the member-specific benefit before initiating an exception.
Does CVS Specialty approval mean the same thing as Caremark PA approval?
Not necessarily. Prior authorization is the coverage-review component. Specialty pharmacy coordination may continue after approval before medication is dispensed. CVS Specialty explains that after applicable PA approval, it may contact the patient to arrange delivery.
Does Caremark PA guarantee that a prescription will process?
PA approval resolves the applicable authorization requirement, but other pharmacy-benefit rules can still affect the claim. Eligibility, pharmacy network, quantity, days’ supply, refill timing, formulary changes, and other benefit conditions should still be considered.
Related Prior Authorization Guides
- Understanding Medicare Prior Authorization Requirements: A Complete Guide to Precertification, Clinical Reviews, and Documentation
- Prescription Prior Authorization Guidelines: Understanding the Difference Between Medical Necessity, Coverage, and Precertification
- TRICARE East Prior Authorization Requirements Explained: How to Handle Urgent Requests, Standard Reviews, and Authorization Follow-Ups
- CareSource Prior Authorization Guidelines 2027: Rules, Forms & Coverage
